Genetic Technologies
GENE
$2.26
Share price
3.54%
Change (1 day)
112.93%
Change (1 year)
Categories
Revenue for Genetic Technologies (GENE)
Revenue in 2008 (TTM): $17.17 M
According to Genetic Technologies's latest financial reports the company's current revenue (TTM) is $17.17 M. In 2007 the company made a revenue of $16.82 M an increase over the years 2006 revenue that were of $7.17 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Genetic Technologies from 2005 to 2008
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2008 (TTM) | $17.17 M | 2.09% |
| 2007 | $16.82 M | 134.32% |
| 2006 | $7.17 M | 11.75% |
| 2005 | $6.42 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $42.85 B | 249,456.90% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $9.25 B | 53,774.52% | 🇺🇸 USA |
 Danaher DHR | $23.89 B | 139,011.80% | 🇺🇸 USA |
 LabCorp LH | $12.90 B | 75,026.78% | 🇺🇸 USA |
 Compugen CGEN | $33.45 M | 94.83% | 🇮🇱 Israel |
 Neogen NEOG | $0.92 B | 5,310.97% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.75 B | 4,285.89% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $0.06 M | -99.60% | 🇺🇸 USA |